Standard BioTools Inc. (LAB)

NASDAQ: LAB · Real-Time Price · USD

0.9550

+0.0224 (2.40%)

Mar 16, 2026, 4:00 PM EDT - Market closed

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Medical Products	85.33M	-	-	-	-
Proteomics	-	135.79M	63.88M	52.50M	67.66M
Proteomics Growth	-	112.56%	21.68%	-22.40%	-
Genomics	-	38.64M	42.46M	45.45M	62.92M
Genomics Growth	-	-8.98%	-6.58%	-27.78%	-
Total	85.33M	174.43M	106.34M	97.95M	130.58M
Total Growth	-51.08%	64.03%	8.57%	-24.99%	-5.47%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Europe, Middle East and Africa (EMEA)	52.32M	36.20M	33.14M	42.72M
Europe, Middle East and Africa (EMEA) Growth	44.52%	9.25%	-22.44%	13.09%
Americas Excl. United States	3.56M	2.10M	2.98M	3.68M
Americas Excl. United States Growth	69.94%	-29.71%	-18.90%	42.19%
Asia-Pacific (Excl. China)	16.85M	7.99M	10.06M	11.48M
Asia-Pacific (Excl. China) Growth	110.85%	-20.52%	-12.42%	-21.80%
United States	89.90M	44.10M	41.00M	60.20M
United States Growth	103.85%	7.56%	-31.89%	-16.39%
China	11.80M	15.95M	10.77M	12.50M
China Growth	-26.02%	48.05%	-13.81%	12.61%
Total	174.43M	106.34M	97.95M	130.58M
Total Growth	64.03%	8.57%	-24.99%	-5.47%

Source: S&P Global Market Intelligence.